Quantcast
Connect with us

Cell-like decoys could mop up viruses in humans – including the one that causes COVID-19

Published

on

The Research Brief is a short take about interesting academic work.

The big idea

Researchers around the world are working frantically to develop COVID-19 vaccines meant to target and attack the SARS-CoV-2 virus. Researchers in my nanoengineering lab are taking a different approach toward stopping SARS-CoV-2. Instead of playing offense and stimulating the immune system to attack the SARS-CoV-2 virus, we’re playing defense. We’re working to shield the healthy human cells the virus invades.

ADVERTISEMENT

Conceptually, the strategy is simple. We create decoys that look like the human cells the SARS-CoV-2 virus invades. So far, we’ve made lung-cell decoys and immune-cell decoys. These cell decoys attract and neutralize the SARS-CoV-2 virus, leaving the real lung or immune cells healthy.

To make the decoys, we collect the outer membranes of the lung or immune cells and wrap them around a core made of biodegradable nanoparticles. From the outside the decoys look the same as the human cells they are impersonating. Our decoys are hundreds of times smaller in diameter than an actual lung or immune cell, but they have all the same cellular hardware sticking out of them.

In this illustration, six decoys surround a SARS-CoV-2 virus particle before it can reach a human cell.
David Baillot, UC San Diego Jacobs School of Engineering, CC BY-ND

We call them “nanosponges” because they soak up harmful pathogens and toxins that attack the cells they impersonate. My team and I first developed the concept 10 years ago, and since then we’ve shown the nanosponges offer a new approach to fighting viral infections like HIV; bacterial infections like methicillin-resistant Staphylococcus aureus, or MRSA, E. coli and sepsis; and inflammatory diseases like rheumatoid arthritis.

We recently published results showing that the SARS-CoV-2 coronavirus binds to these decoy nanosponges, which were more than 90% effective in causing the virus to lose its ability to infect cells in petri dishes. Once the virus is locked into the decoy, it can’t invade any real cells, and is cleared by the body’s immune system.

Why it matters

Vaccines are critical for protecting against viral infections, but as viruses mutate they can render vaccines and treatments ineffective. This is why new flu vaccines are developed each year. Fortunately, SARS-CoV-2 doesn’t appear to mutate as quickly as influenza viruses, but this highlights the need for alternatives that are unaffected by mutations.

ADVERTISEMENT

I’m hopeful that other teams of researchers come up with safe and effective treatments for COVID-19 as soon as possible. But for now, my team is working and planning as if the world is counting on us.

What still isn’t known

The different types of nanosponges we’ve developed are in various stages of pre-clinical development. So far, the results look promising, but there is more work to do to ensure they’re safe and effective.

Cellular nanosponges are a new kind of drug. We made the first nanosponges using human red blood cell membranes, and these are the furthest along in the regulatory process, having undergone all stages of pre-clinical testing.

ADVERTISEMENT

What’s next

Cellics Therapeutics, a startup company I co-founded, is in the process of submitting an investigational new drug application to the FDA for the red blood cell nanosponges to treat bacterial pneumonia. If these red blood cell nanosponges get FDA approval and if the pre-clinical data for the COVID-19 nanosponges keep looking good, the COVID-19 nanosponges could have a clearer path to clinical trials in the years ahead.

We are currently testing the nanosponges for SARS-CoV-2 in animals. If the nanosponges do reach the clinical trial stage, there are several ways of delivering the therapy, including direct delivery into the lung for intubated patients via an inhaler like those used by asthmatic patients or through an intravenous injection.

ADVERTISEMENT

There is also the possibility that our immune-cell nanosponges could soak up the inflammatory cytokine proteins that are triggering the dangerous immune system overreactions in some people suffering from COVID-19.

[You need to understand the coronavirus pandemic, and we can help. Read The Conversation’s newsletter.]The Conversation

Liangfang Zhang, Professor of Nanoengineering, University of California San Diego

ADVERTISEMENT

This article is republished from The Conversation under a Creative Commons license. Read the original article.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

COVID-19

What we know so far about COVID-19 and children

Published

on

President Donald Trump has been censored on Facebook and Twitter after saying children are "almost immune" from COVID-19. What do the facts say?

We know for sure children are less likely to fall seriously ill from the coronavirus, and emerging evidence suggests they're less likely to be infected too.

What's less clear is how much they spread the virus once infected.

- Children rarely become seriously ill -

Under-18s have accounted for just two percent of hospitalized COVID-19 cases and less than 0.1 percent of all deaths in the United States, according to statistics from the Centers for Disease Control and Prevention (CDC).

Continue Reading

Breaking Banner

Angst-ridden Republicans should have acted when Trump put his reelection above national security concerns: conservative columnist

Published

on

Writing in the Washington Post this Thursday, columnist Jennifer Rubin says that Senate Republicans are in serious trouble, especially in light of the stimulus bill they rolled out this week.

According to Rubin, the Senate GOP is in dire straits because "they have allowed the anti-government, anti-science Trump sycophants to disclaim any interest in the bill, thereby handing the reins to Democrats."

Rubin writes that some Republicans saying they want to see essential workers being taken care of in the bill are speaking up too late. "If only they they had some power in February to remove the unfit and corrupt president from office, instead of leaving him there to purge witnesses from his administration, seek vengeance on foes, force out inspectors general and botch the response to the coronavirus," Rubin writes.

Continue Reading
 

Breaking Banner

Anti-mask GOP lawmaker mocks Ohio governor for testing positive for coronavirus

Published

on

Notoriously anti-mask Ohio state Rep. Nino Vitale gloated after Gov. Mike DeWine tested positive for the coronavirus.

The Urbana Republican has questioned masks and opposed other public safety measures imposed by DeWine, also a Republican, and ridiculed the governor after he tested positive for the potentially deadly virus ahead of meeting President Donald Trump.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image